REG - Adv Medical Soln Grp - Trading Update <Origin Href="QuoteRef">AMSU.L</Origin>

Advanced Medical SolutionsAnnouncement

04/07/2017 07:00

RNS Number : 9919J
Advanced Medical Solutions Grp PLC
04 July 2017
4 July
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Trading Update
Winsford, UK:Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces a trading update covering the six-month period 1 January to 30 June 2017.
The Group continues to make good progress and can confirm that trading for the six-month period is in line with the Board's expectations.
Chris Meredith, Chief Executive Officer of AMS, commented:"The Board is pleased with the ongoing strong performance of the business and we are on track for the full year. We remain focused on our strategic objectives to grow organically and through acquisition, whilst delivering innovation that will benefit both patients and surgeons."
The Group expects to publish its Interim Results for the period to 30 June 2017 on 13 September 2017.
For further information, please visitwww.admedsol.comor contact:
Advanced Medical Solutions Group plc
Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director



Consilium Strategic Communications
Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys 



Investec Bank PLC (NOMAD & Broker)
Tel: +44 (0) 20 7597 5970
Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc- seewww.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBandand RESORBA.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please seewww.admedsol.com.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
TSTLLFFRDAIVIID